Skip to content
Cellestetix logo — CX is Ready for Retail

Cellestetix

CX is Ready for Retail

Founded 2020 Seed Total: $4.67M Biotechnology, Health and Wellness +1

General Information

Company Name Cellestetix
Founded Year 2020
Industries Biotechnology, Health and Wellness, Wellness Beauty
Funding Stage Seed
Business Model B2B, D2C, B2B2C
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Cellestetix. To contact Cellestetix, visit cellestetix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cellestetix compare?

A PDF of Cellestetix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cellestetix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cellestetix

Cellestetix, with its slogan "CX is Ready for Retail," is a promising startup in the Biotechnology sector, leveraging breakthroughs in plant-based exosome technology for regenerative beauty and wellness applications. Based in Turkey, this innovative company was founded in 2020 by genetic engineers Dr. Polen Koçak and Dr. Merve Yıldırım, who bring a decade of combined expertise in biotechnology, genetics, and bioengineering to their venture.

Initially focused on R&D for cancer and wound care, Cellestetix strategically pivoted to address the lucrative cosmetic market. This shift has allowed the company to harness the growing demand for beauty and wellness solutions, positioning them strongly within the Wellness Beauty and Health and Wellness industries.

In its recent funding activities, Cellestetix secured a $1.67 million seed investment on 01 February 2025, illustrating investor confidence in its growth potential. This injection of capital is expected to bolster its commercialization efforts and strategic expansion in the fast-evolving biotechnology landscape.

Business keywords: plant-based exosomes, regenerative beauty, wellness applications, genetic engineering, bioengineering, cosmetic technology, skin regeneration, hair regeneration, R&D platform, cancer care innovation, wound care innovation

Services & Products

Development of plant-based exosome technologies
Customizable cosmetic and wellness solutions
Market-ready applications for skin and hair care

Target Customers

Retailers in beauty and wellness industry Consumers seeking innovative skincare solutions Businesses looking for climate-positive, cruelty-free products

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $1.67M -
01 Feb 2025
Seed $2.00M 5
Arya Women's Investment Platform, APY Ventures +3
01 Aug 2024
Seed $1.00M 1
Pragma Capital
01 Mar 2023

Cellestetix Alternatives & Competitors

View All Alternatives
Cellestetix vs

Welcome to Intercytex Ltd. We are a UK Regenerative Medicine product and services company, focused o...

Venture round
6 employees
Biotechnology, Wellness Beauty
Cellestetix vs

Creating advanced regenerative solutions for severe burns with faster production, larger sheets, and...

Series A
Biotechnology, Health and Wellness
Cellestetix vs
Starwood Med Spa
Starwood Med Spa United States

Age with Beauty

10 employees
Health Care, Health and Wellness

FAQ About Cellestetix

CX is Ready for Retail
Cellestetix was founded in 2020.
Cellestetix operates in Biotechnology, Health and Wellness and Wellness Beauty. Its work centres on plant-based exosomes, regenerative beauty, wellness applications and genetic engineering. Its customers include Retailers in beauty and wellness industry, Consumers seeking innovative skincare solutions and Businesses looking for climate-positive, cruelty-free products.
Cellestetix has a B2B, D2C and B2B2C business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Cellestetix has completed 3 funding rounds, raising a total of $4.67M. The latest funding stage is Seed.
Cellestetix offers: Development of plant-based exosome technologies, Customizable cosmetic and wellness solutions, Market-ready applications for skin and hair care.
Top alternatives and competitors to Cellestetix include Intercytex Ltd, Upside Biotechnologies, Starwood Med Spa, HOLY PIT GmbH, ExoCoBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellestetix and Intercytex Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cellestetix, https://bouncewatch.com/company/cellestetix, updated 18 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout